The Laboratory for Functional Omics and Innovative Chinese Medicine, Innovative Drug Research Center, Chongqing University, Chongqing 401331, P.R. China.
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Sci Rep. 2016 Apr 14;6:24099. doi: 10.1038/srep24099.
Uropathogenic Escherichia coli (UPEC) growth in women's bladders during urinary tract infection (UTI) incurs substantial chemical exchange, termed the "interactive metabolome", which primarily accounts for the metabolic costs (utilized metabolome) and metabolic donations (excreted metabolome) between UPEC and human urine. Here, we attempted to identify the individualized interactive metabolome between UPEC and human urine. We were able to distinguish UPEC from non-UPEC by employing a combination of metabolomics and genetics. Our results revealed that the interactive metabolome between UPEC and human urine was markedly different from that between non-UPEC and human urine, and that UPEC triggered much stronger perturbations in the interactive metabolome in human urine. Furthermore, siderophore biosynthesis coordinately modulated the individualized interactive metabolome, which we found to be a critical component of UPEC virulence. The individualized virulence-associated interactive metabolome contained 31 different metabolites and 17 central metabolic pathways that were annotated to host these different metabolites, including energetic metabolism, amino acid metabolism, and gut microbe metabolism. Changes in the activities of these pathways mechanistically pinpointed the virulent capability of siderophore biosynthesis. Together, our findings provide novel insights into UPEC virulence, and we propose that siderophores are potential targets for further discovery of drugs to treat UPEC-induced UTI.
尿路致病性大肠杆菌(UPEC)在女性膀胱中引起尿路感染(UTI)时会发生大量的化学交换,称为“互代谢组”,主要包括 UPEC 和人尿之间的代谢成本(利用代谢组)和代谢捐赠(排泄代谢组)。在这里,我们试图确定 UPEC 和人尿之间的个体化互代谢组。我们能够通过代谢组学和遗传学的结合来区分 UPEC 和非 UPEC。我们的结果表明,UPEC 和人尿之间的互代谢组与非 UPEC 和人尿之间的互代谢组有明显的不同,而且 UPEC 在人尿中的互代谢组中引发了更强的干扰。此外,铁载体生物合成协同调节个体化互代谢组,我们发现这是 UPEC 毒力的关键组成部分。个体化与毒力相关的互代谢组包含 31 种不同的代谢物和 17 种中央代谢途径,这些途径被注释为宿主这些不同代谢物,包括能量代谢、氨基酸代谢和肠道微生物代谢。这些途径活性的变化从机制上指出了铁载体生物合成的毒力能力。总之,我们的发现为 UPEC 毒力提供了新的见解,我们提出铁载体是进一步发现治疗 UPEC 引起的 UTI 的药物的潜在靶点。